CoChat
Sign Up
Cited by 248

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

The miRNA–target interactions: An underestimated intricacy

Diener, Caroline, Keller, Andreas, Meese, Eckart·2024·Nucleic Acids Research
DOI 10.1093/nar/gkad1142PMC PMC10899768
Open this paper in CoChat — free account

Abstract

MicroRNAs (miRNAs) play indispensable roles in posttranscriptional gene regulation. Their cellular regulatory impact is determined not solely by their sheer number, which likely amounts to >2000 individual miRNAs in human, than by the regulatory effectiveness of single miRNAs. Although, one begins to develop an understanding of the complex mechanisms underlying miRNA–target interactions (MTIs), the overall knowledge of MTI functionality is still rather patchy. In this critical review, we summarize key features of mammalian MTIs. We especially highlight latest insights on (i) the dynamic make-up of miRNA binding sites including non-canonical binding sites, (ii) the cooperativity between miRNA binding sites, (iii) the adaptivity of MTIs through sequence modifications, (iv) the bearing of intra-cellular miRNA localization changes and (v) the role of cell type and cell status specific miRNA interaction partners. The MTI biology is discussed against the background of state-of-the-art approaches with particular emphasis on experimental strategies for evaluating miRNA functionality.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkad1142

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical Abstract
Graphical Abstract CC BY · PubMed Central
Figure 1. Scheme of the canonical miRNA biogenesis pathway. The first step of the canonical mammalian miRNA biogenesis encompasses the transcription of a primary miRNA (pri-miRNA) from endogenous DNA loci by RNA polymerase II. The primary transcript includes an imperfect hairpin structure that is cleaved by the DROSHA-DGCR8 complex into a 60–90 nt long precursor miRNA (pre-miRNA) with a two nucleotide (nt) 3′ overhang. The pre-miRNA is transported from the nucleus to cytoplasm through the export protein XPO5 in a RAN-GTP dependent manner. The cytoplasmatic miRNA becomes a substrate for the RNase DICER that forms a complex with the double-stranded RNA-binding protein TRBP. Following removal of the loop structure, a miRNA duplex of 19–22 nt in length interacts with proteins of the Argonaute (Ago) family. One strand is incorporated into the RNA induced silencing complex (RISC). The strand with a higher content of purines and a lower thermodynamic stability of the 5′ end takes the dominant biological functionality i.e. it acts as functional miRNA that confers post-transcriptional regulation through RISC catalyzed mRNA degradation, mRNA destabilization or translation repression. [The functional portion of the miRNAs are indicated in red, the mRNA target is shown as a solid blue line, and the degraded mRNA as a dashed blue line. Interactions between miRNA and mRNA are indicated by opposite comb-shaped lines. The Drosha–DGCR8 complex is depicted by pink bodies, the export protein XPO5 by a violet cylinder, the DICER-TRBP complex by blue bodies, the RISC by a turquoise body and ribosomes by green bodies.]
Figure 1. Scheme of the canonical miRNA biogenesis pathway. The first step of the canonical mammalian miRNA biogenesis encompasses the transcription of a primary miRNA (pri-miRNA) from endogenous DNA loci by RNA polymerase II. The primary transcript includes an imperfect hairpin structure that is cleaved by the DROSHA-DGCR8 complex into a 60–90 nt long precursor miRNA (pre-miRNA) with a two nucleotide (nt) 3′ overhang. The pre-miRNA is transported from the nucleus to cytoplasm through the export protein XPO5 in a RAN-GTP dependent manner. The cytoplasmatic miRNA becomes a substrate for the RNase DICER that forms a complex with the double-stranded RNA-binding protein TRBP. Following removal of the loop structure, a miRNA duplex of 19–22 nt in length interacts with proteins of the Argonaute (Ago) family. One strand is incorporated into the RNA induced silencing complex (RISC). The strand with a higher content of purines and a lower thermodynamic stability of the 5′ end takes the dominant biological functionality i.e. it acts as functional miRNA that confers post-transcriptional regulation through RISC catalyzed mRNA degradation, mRNA destabilization or translation repression. [The functional portion of the miRNAs are indicated in red, the mRNA target is shown as a solid blue line, and the degraded mRNA as a dashed blue line. Interactions between miRNA and mRNA are indicated by opposite comb-shaped lines. The Drosha–DGCR8 complex is depicted by pink bodies, the export protein XPO5 by a violet cylinder, the DICER-TRBP complex by blue bodies, the RISC by a turquoise body and ribosomes by green bodies.]CC BY · PubMed Central
Figure 2. Overview on miRNA–target bindings and miRNA localization changes. (A) The regulatory capacity of MTIs is a function of the length of binding interaction between the miRNA seed sequence and the mRNA target, the presence of 3′ binding sites, the cooperation between multiple miRNA-responsive elements and the modification of both, the miRNAs and target sequences through e.g. A-to-I RNA editing or 3′UTR shortening. (B) Intra-cellular miRNA sub-localizations include membranous comparts like the nucleus or mitochondria and non-membranous comparts like granules. Extracellular miRNA localization can result from secretion of vesicles like exosomes. [MiRNAs are indicated as red lines, mRNAs as blue lines, interactions between miRNA and mRNA by opposite comb-shaped lines. Length variations are depicted by dashed two-sided arrows and translocations by solid two-sides arrows. Ribosomes are shown as green bodies, RISC as turquoise bodies. Sequence shortening is symbolized by cutting scissors and sequence exchanges by dotted rectangles.]
Figure 2. Overview on miRNA–target bindings and miRNA localization changes. (A) The regulatory capacity of MTIs is a function of the length of binding interaction between the miRNA seed sequence and the mRNA target, the presence of 3′ binding sites, the cooperation between multiple miRNA-responsive elements and the modification of both, the miRNAs and target sequences through e.g. A-to-I RNA editing or 3′UTR shortening. (B) Intra-cellular miRNA sub-localizations include membranous comparts like the nucleus or mitochondria and non-membranous comparts like granules. Extracellular miRNA localization can result from secretion of vesicles like exosomes. [MiRNAs are indicated as red lines, mRNAs as blue lines, interactions between miRNA and mRNA by opposite comb-shaped lines. Length variations are depicted by dashed two-sided arrows and translocations by solid two-sides arrows. Ribosomes are shown as green bodies, RISC as turquoise bodies. Sequence shortening is symbolized by cutting scissors and sequence exchanges by dotted rectangles.]CC BY · PubMed Central
Figure 3. Scheme representation on the diversity of miRNA interactomes. (A) Different miRNAs compete for cellular resources, including the available RISCs. There are specific preferences of the miRNAs for their interaction with different Ago paralogs as central part of the RISC. (B) Target mRNAs and competing endogenous RNA species, like circular RNAs (circRNAs), contest for miRNA binding. (C) Different mRNAs compete for RISC bound miRNAs. (D) RNA-binding proteins (RBPs) modulate accessibility of a mRNA target site for miRNAs. [Different miRNAs are depicted in red, pink and orange, respectively. Different mRNAs (targets) are shown in shades of blue and ceRNAs in violet. A different molecular abundance is indicated by a different number of miRNAs or mRNAs, respectively. RISCs are shown by turquoise and RNA binding proteins by greyish bodies. Functional interactions are indicated by arrows and sequence interactions by opposite comb-shaped lines.]
Figure 3. Scheme representation on the diversity of miRNA interactomes. (A) Different miRNAs compete for cellular resources, including the available RISCs. There are specific preferences of the miRNAs for their interaction with different Ago paralogs as central part of the RISC. (B) Target mRNAs and competing endogenous RNA species, like circular RNAs (circRNAs), contest for miRNA binding. (C) Different mRNAs compete for RISC bound miRNAs. (D) RNA-binding proteins (RBPs) modulate accessibility of a mRNA target site for miRNAs. [Different miRNAs are depicted in red, pink and orange, respectively. Different mRNAs (targets) are shown in shades of blue and ceRNAs in violet. A different molecular abundance is indicated by a different number of miRNAs or mRNAs, respectively. RISCs are shown by turquoise and RNA binding proteins by greyish bodies. Functional interactions are indicated by arrows and sequence interactions by opposite comb-shaped lines.]CC BY · PubMed Central
Figure 4. Experimental strategies for the identification of miRNA targets. MiRNA targets can be identified by comparisons of e.g. healthy vs. diseased cells or by downstream analysis upon experimental miRNA manipulations. Differential abundances of miRNAs and target mRNA are detectable by qPCR, microarray analyses, or next generation sequencing (NGS), differential levels of target proteins by western blot, immunostaining or mass spectrometry, direct interaction between miRNAs and their target mRNA by reporter assays or co-precipitation analyses, and down-stream miRNA effects by proliferation assays, viability assays or by assays tailored for specific miRNA regulated cell functions. [MiRNAs are indicated in red, target mRNAs in blue, and target proteins as blue spherical bodies. Interactions between miRNA and mRNA are depicted by opposite comb-shaped lines. Degradation of mRNA is indicated by dashed lines and reduction in protein expression by dashed outlines. Functional effects are symbolized by a grey shaded receptor icon. Ribosomes are shown as green bodies, RISCs as turquoise bodies.]
Figure 4. Experimental strategies for the identification of miRNA targets. MiRNA targets can be identified by comparisons of e.g. healthy vs. diseased cells or by downstream analysis upon experimental miRNA manipulations. Differential abundances of miRNAs and target mRNA are detectable by qPCR, microarray analyses, or next generation sequencing (NGS), differential levels of target proteins by western blot, immunostaining or mass spectrometry, direct interaction between miRNAs and their target mRNA by reporter assays or co-precipitation analyses, and down-stream miRNA effects by proliferation assays, viability assays or by assays tailored for specific miRNA regulated cell functions. [MiRNAs are indicated in red, target mRNAs in blue, and target proteins as blue spherical bodies. Interactions between miRNA and mRNA are depicted by opposite comb-shaped lines. Degradation of mRNA is indicated by dashed lines and reduction in protein expression by dashed outlines. Functional effects are symbolized by a grey shaded receptor icon. Ribosomes are shown as green bodies, RISCs as turquoise bodies.]CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 168

  1. Diener, 2022, Emerging concepts of miRNA therapeutics: from cells to clinic, Trends Genet., 38, 613, 10.1016/j.tig.2022.02.006 · DOI
  2. Fehlmann, 2020, Common diseases alter the physiological age-related blood microRNA profile, Nat. Commun., 11, 5958, 10.1038/s41467-020-19665-1 · DOI
  3. Brancati, 2018, An interplay of miRNA abundance and target site architecture determines miRNA activity and specificity, Nucleic Acids Res., 46, 3259, 10.1093/nar/gky201 · DOI
  4. Turunen, 2019, Changes in nuclear and cytoplasmic microRNA distribution in response to hypoxic stress, Sci. Rep., 9, 10332, 10.1038/s41598-019-46841-1 · DOI
  5. Bartel, 2004, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
  6. Leitao, 2022, A structural view of miRNA biogenesis and function, Noncoding RNA, 8, 10
  7. Gregory, 2005, Human RISC couples microRNA biogenesis and posttranscriptional gene silencing, Cell, 123, 631, 10.1016/j.cell.2005.10.022 · DOI · Paper page
  8. Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15, 10.1016/j.cell.2004.12.035 · DOI · Paper page
  9. Gu, 2009, Biological basis for restriction of microRNA targets to the 3′ untranslated region in mammalian mRNAs, Nat. Struct. Mol. Biol., 16, 144, 10.1038/nsmb.1552 · DOI
  10. Lytle, 2007, Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR, Proc. Natl. Acad. Sci. U.S.A., 104, 9667, 10.1073/pnas.0703820104 · DOI
  11. Wu, 2006, MicroRNAs direct rapid deadenylation of mRNA, Proc. Natl. Acad. Sci. U.S.A., 103, 4034, 10.1073/pnas.0510928103 · DOI
  12. Behm-Ansmant, 2006, mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes, Genes Dev., 20, 1885, 10.1101/gad.1424106 · DOI
  13. Eichhorn, 2014, mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues, Mol. Cell, 56, 104, 10.1016/j.molcel.2014.08.028 · DOI · Paper page
  14. Oliveto, 2017, Role of microRNAs in translation regulation and cancer, World J. Biol. Chem., 8, 45, 10.4331/wjbc.v8.i1.45 · DOI
  15. Vasudevan, 2007, Switching from repression to activation: microRNAs can up-regulate translation, Science, 318, 1931, 10.1126/science.1149460 · DOI
  16. Ni, 2016, miRNA-dependent activation of mRNA translation, Microrna, 5, 83, 10.2174/2211536605666160825151201 · DOI
  17. Ludwig, 2017, Bias in recent miRBase annotations potentially associated with RNA quality issues, Sci. Rep., 7, 5162, 10.1038/s41598-017-05070-0 · DOI · Paper page
  18. Kozomara, 2019, miRBase: from microRNA sequences to function, Nucleic Acids Res., 47, D155, 10.1093/nar/gky1141 · DOI · Paper page
  19. Alles, 2019, An estimate of the total number of true human miRNAs, Nucleic Acids Res., 47, 3353, 10.1093/nar/gkz097 · DOI · Paper page
  20. Fromm, 2015, A uniform system for the annotation of vertebrate microRNA genes and the evolution of the human microRNAome, Annu. Rev. Genet., 49, 213, 10.1146/annurev-genet-120213-092023 · DOI
  21. Johnson, 2022, Prioritizing annotated miRNAs: only a small percentage are candidates for biological regulation, 10.1101/2022.10.18.512653 · DOI
  22. Fromm, 2020, Quo vadis microRNAs?, Trends Genet., 36, 461, 10.1016/j.tig.2020.03.007 · DOI · Paper page
  23. Backes, 2018, miRCarta: a central repository for collecting miRNA candidates, Nucleic Acids Res., 46, D160, 10.1093/nar/gkx851 · DOI
  24. Fromm, 2022, MirGeneDB 2.1: toward a complete sampling of all major animal phyla, Nucleic Acids Res., 50, D204, 10.1093/nar/gkab1101 · DOI · Paper page
  25. Kim, 2021, A quantitative map of human primary microRNA processing sites, Mol. Cell, 81, 3422, 10.1016/j.molcel.2021.07.002 · DOI
  26. Rice, 2020, Functional atlas of primary miRNA maturation by the microprocessor, Mol. Cell, 80, 892, 10.1016/j.molcel.2020.10.028 · DOI
  27. Vlachos, 2015, DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions, Nucleic Acids Res., 43, D153, 10.1093/nar/gku1215 · DOI
  28. Huang, 2022, miRTarBase update 2022: an informative resource for experimentally validated miRNA–target interactions, Nucleic Acids Res., 50, D222, 10.1093/nar/gkab1079 · DOI
  29. McGeary, 2019, The biochemical basis of microRNA targeting efficacy, Science, 366, eaav1741, 10.1126/science.aav1741 · DOI
  30. Bartel, 2009, MicroRNAs: target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 · DOI · Paper page
  31. Hart, 2018, The deterministic role of 5-mers in microRNA-gene targeting, RNA Biol., 15, 819
  32. Grimson, 2007, MicroRNA targeting specificity in mammals: determinants beyond seed pairing, Mol. Cell, 27, 91, 10.1016/j.molcel.2007.06.017 · DOI · Paper page
  33. McGeary, 2022, MicroRNA 3′-compensatory pairing occurs through two binding modes, with affinity shaped by nucleotide identity and position, eLife, 11, e69803, 10.7554/eLife.69803 · DOI
  34. Lal, 2009, miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to “seedless” 3′UTR microRNA recognition elements, Mol. Cell, 35, 610, 10.1016/j.molcel.2009.08.020 · DOI
  35. Flamand, 2017, A non-canonical site reveals the cooperative mechanisms of microRNA-mediated silencing, Nucleic Acids Res., 45, 7212, 10.1093/nar/gkx340 · DOI
  36. Farberov, 2023, Multiple copies of microRNA binding sites in long 3′UTR variants regulate axonal translation, Cells, 12, 233, 10.3390/cells12020233 · DOI
  37. Gebert, 2019, Regulation of microRNA function in animals, Nat. Rev. Mol. Cell Biol., 20, 21, 10.1038/s41580-018-0045-7 · DOI · Paper page
  38. Broderick, 2011, Argonaute protein identity and pairing geometry determine cooperativity in mammalian RNA silencing, RNA, 17, 1858, 10.1261/rna.2778911 · DOI
  39. Shu, 2017, Dynamic and modularized MicroRNA regulation and its implication in human cancers, Sci. Rep., 7, 13356, 10.1038/s41598-017-13470-5 · DOI
  40. Saetrom, 2007, Distance constraints between microRNA target sites dictate efficacy and cooperativity, Nucleic Acids Res., 35, 2333, 10.1093/nar/gkm133 · DOI
  41. Diener, 2023, Outside the limit: questioning the distance restrictions for cooperative miRNA binding sites, Cell. Mol. Biol. Lett., 28, 8, 10.1186/s11658-023-00421-4 · DOI
  42. Ishiguro, 2018, Base-pairing probability in the microRNA stem region affects the binding and editing specificity of human A-to-I editing enzymes ADAR1-p110 and ADAR2, RNA Biol., 15, 976, 10.1080/15476286.2018.1486658 · DOI
  43. Correia de Sousa, 2019, Deciphering miRNAs’ action through miRNA editing, Int. J. Mol. Sci., 20, 6249, 10.3390/ijms20246249 · DOI
  44. Li, 2018, The landscape of miRNA editing in animals and its impact on miRNA biogenesis and targeting, Genome Res., 28, 132, 10.1101/gr.224386.117 · DOI
  45. Marceca, 2021, Detecting and characterizing A-To-I microRNA editing in cancer, Cancers (Basel), 13, 1699, 10.3390/cancers13071699 · DOI
  46. Sharma, 2017, Transient overexpression of exogenous APOBEC3A causes C-to-U RNA editing of thousands of genes, RNA Biol., 14, 603, 10.1080/15476286.2016.1184387 · DOI
  47. Aparicio-Puerta, 2023, isomiRdb: microRNA expression at isoform resolution, Nucleic Acids Res., 51, D179, 10.1093/nar/gkac884 · DOI
  48. Wang, 2021, MiR-CLIP reveals iso-miR selective regulation in the miR-124 targetome, Nucleic Acids Res., 49, 25, 10.1093/nar/gkaa1117 · DOI
  49. Kim, 2019, Bias-minimized quantification of microRNA reveals widespread alternative processing and 3′ end modification, Nucleic Acids Res., 47, 2630, 10.1093/nar/gky1293 · DOI
  50. Yu, 2017, Naturally existing isoforms of miR-222 have distinct functions, Nucleic Acids Res., 45, 11371, 10.1093/nar/gkx788 · DOI
  51. Brummer, 2017, Structure-mediated modulation of mRNA abundance by A-to-I editing, Nat. Commun., 8, 1255, 10.1038/s41467-017-01459-7 · DOI
  52. Navarro, 2021, Dynamic variations of 3′UTR length reprogram the mRNA regulatory landscape, Biomedicines, 9, 1560, 10.3390/biomedicines9111560 · DOI
  53. Gan, 2019, The role of tertiary structure in MicroRNA target recognition, Methods Mol. Biol., 1970, 43, 10.1007/978-1-4939-9207-2_4 · DOI
  54. Rolle, 2016, The sequence and structure determine the function of mature human miRNAs, PLoS One, 11, e0151246, 10.1371/journal.pone.0151246 · DOI
  55. Akgul, 2018, Intracytoplasmic re-localization of miRISC Complexes, Front. Genet., 9, 403, 10.3389/fgene.2018.00403 · DOI
  56. Younger, 2011, Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters, Nucleic Acids Res., 39, 5682, 10.1093/nar/gkr155 · DOI
  57. Johnson, 2023, RNAi in cell nuclei: potential for a new layer of biological regulation and a new strategy for therapeutic discovery, RNA, 29, 415, 10.1261/rna.079500.122 · DOI
  58. Kim, 2008, MicroRNA-directed transcriptional gene silencing in mammalian cells, Proc. Natl. Acad. Sci. U.S.A., 105, 16230, 10.1073/pnas.0808830105 · DOI
  59. Huang, 2013, Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells, PLoS Genet., 9, e1003821, 10.1371/journal.pgen.1003821 · DOI
  60. Wei, 2014, Importin 8 regulates the transport of mature microRNAs into the cell nucleus, J. Biol. Chem., 289, 10270, 10.1074/jbc.C113.541417 · DOI
  61. Chaston, 2017, Structural characterisation of TNRC6A nuclear localisation signal in complex with importin-alpha, PLoS One, 12, e0183587, 10.1371/journal.pone.0183587 · DOI
  62. Castanotto, 2009, CRM1 mediates nuclear-cytoplasmic shuttling of mature microRNAs, Proc. Natl. Acad. Sci. U.S.A., 106, 21655, 10.1073/pnas.0912384106 · DOI
  63. Hwang, 2007, A hexanucleotide element directs microRNA nuclear import, Science, 315, 97, 10.1126/science.1136235 · DOI
  64. Jeffries, 2011, Nuclear and cytoplasmic localization of neural stem cell microRNAs, RNA, 17, 675, 10.1261/rna.2006511 · DOI
  65. Sadakierska-Chudy, 2020, MicroRNAs: diverse mechanisms of action and heir potential applications as cancer epi-therapeutics, Biomolecules, 10, 1285, 10.3390/biom10091285 · DOI
  66. Liu, 2018, Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer, Mol. Cancer, 17, 64, 10.1186/s12943-018-0765-5 · DOI
  67. Chaluvally-Raghavan, 2016, Direct upregulation of STAT3 by MicroRNA-551b-3p deregulates growth and metastasis of ovarian cancer, Cell Rep., 15, 1493, 10.1016/j.celrep.2016.04.034 · DOI
  68. Guo, 2021, Nuclear miR-30b-5p suppresses TFEB-mediated lysosomal biogenesis and autophagy, Cell Death Differ., 28, 320, 10.1038/s41418-020-0602-4 · DOI
  69. Yan, 2019, Mitochondrial miR-762 regulates apoptosis and myocardial infarction by impairing ND2, Cell Death. Dis., 10, 500, 10.1038/s41419-019-1734-7 · DOI
  70. Diener, 2023, Time-resolved RNA signatures of CD4+ T cells in Parkinson's disease, Cell Death Discov., 9, 18, 10.1038/s41420-023-01333-0 · DOI
  71. Shepherd, 2017, Exploring the mitochondrial microRNA import pathway through polynucleotide phosphorylase (PNPase), J. Mol. Cell Cardiol., 110, 15, 10.1016/j.yjmcc.2017.06.012 · DOI
  72. Vendramin, 2017, Non-coding RNAs: the dark side of nuclear-mitochondrial communication, EMBO J., 36, 1123, 10.15252/embj.201695546 · DOI
  73. Luo, 2018, P-Bodies: composition, properties, and functions, Biochemistry, 57, 2424, 10.1021/acs.biochem.7b01162 · DOI
  74. Pitchiaya, 2019, Dynamic recruitment of single RNAs to processing bodies depends on RNA functionality, Mol. Cell, 74, 521, 10.1016/j.molcel.2019.03.001 · DOI
  75. Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat. Cell Biol., 9, 654, 10.1038/ncb1596 · DOI · Paper page
  76. Garcia-Martin, 2022, MicroRNA sequence codes for small extracellular vesicle release and cellular retention, Nature, 601, 446, 10.1038/s41586-021-04234-3 · DOI
  77. Narayan, 2017, Functionally distinct roles for different miR-155 expression levels through contrasting effects on gene expression, in acute myeloid leukaemia, Leukemia, 31, 808, 10.1038/leu.2016.279 · DOI
  78. Brown, 2007, Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state, Nat. Biotechnol., 25, 1457, 10.1038/nbt1372 · DOI
  79. Sabi, 2019, Modelling and measuring intracellular competition for finite resources during gene expression, J. R. Soc. Interface, 16, 20180887, 10.1098/rsif.2018.0887 · DOI
  80. Grimm, 2011, The dose can make the poison: lessons learned from adverse in vivo toxicities caused by RNAi overexpression, Silence, 2, 8, 10.1186/1758-907X-2-8 · DOI
  81. Diener, 2020, Quantitative and time-resolved miRNA pattern of early human T cell activation, Nucleic Acids Res., 48, 10164, 10.1093/nar/gkaa788 · DOI
  82. Bosson, 2014, Endogenous miRNA and target concentrations determine susceptibility to potential ceRNA competition, Mol. Cell, 56, 347, 10.1016/j.molcel.2014.09.018 · DOI
  83. Lai, 2019, Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer, Nucleic Acids Res., 47, 7753, 10.1093/nar/gkz638 · DOI
  84. Baccarini, 2011, Kinetic analysis reveals the fate of a microRNA following target regulation in mammalian cells, Curr. Biol., 21, 369, 10.1016/j.cub.2011.01.067 · DOI
  85. Hutvagner, 2002, A microRNA in a multiple-turnover RNAi enzyme complex, Science, 297, 2056, 10.1126/science.1073827 · DOI · Paper page
  86. Haley, 2004, Kinetic analysis of the RNAi enzyme complex, Nat. Struct. Mol. Biol., 11, 599, 10.1038/nsmb780 · DOI · Paper page
  87. Su, 2009, Essential and overlapping functions for mammalian Argonautes in microRNA silencing, Genes Dev., 23, 304, 10.1101/gad.1749809 · DOI
  88. Nakanishi, 2022, Anatomy of four human Argonaute proteins, Nucleic Acids Res., 50, 6618, 10.1093/nar/gkac519 · DOI
  89. Voller, 2016, Argonaute family protein expression in normal tissue and cancer entities, PLoS One, 11, e0161165, 10.1371/journal.pone.0161165 · DOI
  90. Dueck, 2012, microRNAs associated with the different human Argonaute proteins, Nucleic Acids Res., 40, 9850, 10.1093/nar/gks705 · DOI · Paper page
  91. Turchinovich, 2012, Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma, RNA Biol., 9, 1066, 10.4161/rna.21083 · DOI · Paper page
  92. Burroughs, 2011, Deep-sequencing of human Argonaute-associated small RNAs provides insight into miRNA sorting and reveals Argonaute association with RNA fragments of diverse origin, RNA Biol., 8, 158, 10.4161/rna.8.1.14300 · DOI
  93. Liu, 2021, Repressing Ago2 mRNA translation by Trim71 maintains pluripotency through inhibiting let-7 microRNAs, eLife, 10, e66288, 10.7554/eLife.66288 · DOI
  94. Pawlica, 2019, How complementary targets expose the microRNA 3′ end for tailing and trimming during target-directed microRNA degradation, Cold Spring Harb. Symp. Quant. Biol., 84, 179, 10.1101/sqb.2019.84.039321 · DOI
  95. Park, 2017, Non-canonical targets destabilize microRNAs in human Argonautes, Nucleic Acids Res., 45, 1569
  96. Ghini, 2018, Endogenous transcripts control miRNA levels and activity in mammalian cells by target-directed miRNA degradation, Nat. Commun., 9, 3119, 10.1038/s41467-018-05182-9 · DOI
  97. Haas, 2016, Identification of factors involved in target RNA-directed microRNA degradation, Nucleic Acids Res., 44, 2873, 10.1093/nar/gkw040 · DOI
  98. Sheu-Gruttadauria, 2019, Structural Basis for Target-Directed MicroRNA Degradation, Mol. Cell, 75, 1243, 10.1016/j.molcel.2019.06.019 · DOI · Paper page
  99. Mukherji, 2011, MicroRNAs can generate thresholds in target gene expression, Nat. Genet., 43, 854, 10.1038/ng.905 · DOI
  100. Thomson, 2016, Endogenous microRNA sponges: evidence and controversy, Nat. Rev. Genet., 17, 272, 10.1038/nrg.2016.20 · DOI · Paper page
  101. Cremer, 2019, Hematopoietic deficiency of the long noncoding RNA MALAT1 promotes atherosclerosis and plaque inflammation, Circulation, 139, 1320, 10.1161/CIRCULATIONAHA.117.029015 · DOI
  102. Karagkouni, 2021, Characterizing miRNA-lncRNA Interplay, Methods Mol. Biol., 2372, 243, 10.1007/978-1-0716-1697-0_21 · DOI
  103. Bosia, 2013, Modelling competing endogenous RNA networks, PLoS One, 8, e66609, 10.1371/journal.pone.0066609 · DOI
  104. Kakumani, 2022, AGO-RBP crosstalk on target mRNAs: implications in miRNA-guided gene silencing and cancer, Transl Oncol., 21, 101434, 10.1016/j.tranon.2022.101434 · DOI
  105. Kim, 2021, The regulatory impact of RNA-binding proteins on microRNA targeting, Nat. Commun., 12, 5057, 10.1038/s41467-021-25078-5 · DOI
  106. Li, 2018, Transcriptome-wide identification and validation of interactions between the miRNA Machinery and HuR on mRNA targets, J. Mol. Biol., 430, 285, 10.1016/j.jmb.2017.12.006 · DOI
  107. Cottrell, 2018, PTRE-seq reveals mechanism and interactions of RNA binding proteins and miRNAs, Nat. Commun., 9, 301, 10.1038/s41467-017-02745-0 · DOI
  108. Nussbacher, 2018, Systematic discovery of RNA binding proteins that regulate MicroRNA levels, Mol. Cell, 69, 1005, 10.1016/j.molcel.2018.02.012 · DOI
  109. White, 2017, AUF1 regulation of coding and noncoding RNA, Wiley Interdiscip. Rev. RNA, 8, 10.1002/wrna.1393 · DOI
  110. Lambert, 2018, The RNA helicase DDX17 controls the transcriptional activity of REST and the expression of proneural microRNAs in neuronal differentiation, Nucleic Acids Res., 46, 7686, 10.1093/nar/gky545 · DOI
  111. Treiber, 2017, A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis, Mol. Cell, 66, 270, 10.1016/j.molcel.2017.03.014 · DOI
  112. Kern, 2021, Validation of human microRNA target pathways enables evaluation of target prediction tools, Nucleic Acids Res., 49, 127, 10.1093/nar/gkaa1161 · DOI
  113. Hart, 2019, miR-34a as hub of T cell regulation networks, J. Immunother. Cancer, 7, 187, 10.1186/s40425-019-0670-5 · DOI
  114. Kehl, 2020, miRPathDB 2.0: a novel release of the miRNA Pathway Dictionary Database, Nucleic Acids Res., 48, D142, 10.1093/nar/gkz1022 · DOI
  115. Kern, 2020, What's the target: understanding two decades of in silico microRNA–target prediction, Brief Bioinform., 21, 1999, 10.1093/bib/bbz111 · DOI
  116. Gerstner, 2020, GeneTrail 3: advanced high-throughput enrichment analysis, Nucleic Acids Res., 48, W515, 10.1093/nar/gkaa306 · DOI
  117. Hart, 2023, miR-34a-5p as molecular hub of pathomechanisms in Huntington's disease, Mol. Med., 29, 43, 10.1186/s10020-023-00640-7 · DOI
  118. Khan, 2009, Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs, Nat. Biotechnol., 27, 549, 10.1038/nbt.1543 · DOI · Paper page
  119. Patutina, 2022, Bulge-forming miRNases cleave oncogenic miRNAs at the central loop region in a sequence-specific manner, Int. J. Mol. Sci., 23, 6562, 10.3390/ijms23126562 · DOI
  120. Meng, 2017, Small RNA zippers lock miRNA molecules and block miRNA function in mammalian cells, Nat. Commun., 8, 13964, 10.1038/ncomms13964 · DOI
  121. Schaefer, 2022, Global and precise identification of functional miRNA targets in mESCs by integrative analysis, EMBO Rep., 23, e54762, 10.15252/embr.202254762 · DOI
  122. Chang, 2016, CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo, Sci. Rep., 6, 22312, 10.1038/srep22312 · DOI
  123. Jeong, 2017, Knockout of miR-221 and miR-222 reveals common and specific targets for paralogous miRNAs, RNA Biol., 14, 197, 10.1080/15476286.2016.1269994 · DOI
  124. Menegatti, 2022, Changes of protein expression after CRISPR/Cas9 knockout of miRNA-142 in cell lines derived from diffuse large B-cell lymphoma, Cancers (Basel), 14, 5031, 10.3390/cancers14205031 · DOI
  125. Murakami, 2014, Tiny masking locked nucleic acids effectively bind to mRNA and inhibit binding of microRNAs in relation to thermodynamic stability, Biomed. Rep., 2, 509, 10.3892/br.2014.260 · DOI
  126. Sultan, 2020, A peptide nucleic acid (PNA) masking the miR-145-5p binding site of the 3′UTR of the cystic fibrosis transmembrane conductance regulator (CFTR) mRNA enhances CFTR expression in Calu-3 cells, Molecules, 25, 1677, 10.3390/molecules25071677 · DOI
  127. Jin, 2015, Transfection of microRNA mimics should be used with caution, Front. Genet., 6, 340, 10.3389/fgene.2015.00340 · DOI
  128. Pitchiaya, 2017, Resolving subcellular miRNA trafficking and turnover at single-molecule resolution, Cell Rep., 19, 630, 10.1016/j.celrep.2017.03.075 · DOI · Paper page
  129. Kingston, 2019, Global analyses of the dynamics of mammalian microRNA metabolism, Genome Res., 29, 1777, 10.1101/gr.251421.119 · DOI · Paper page
  130. Huang, 2013, Proteomics for understanding miRNA biology, Proteomics, 13, 558, 10.1002/pmic.201200339 · DOI
  131. Wen, 2015, Transcriptome dynamics of the microRNA inhibition response, Nucleic Acids Res., 43, 6207, 10.1093/nar/gkv603 · DOI
  132. Sindhu, 2021, MicroRNA interactome multiomics characterization for cancer research and personalized medicine: an expert review, OMICS, 25, 545, 10.1089/omi.2021.0087 · DOI
  133. Seo, 2017, Integration of MicroRNA, mRNA, and protein expression data for the identification of cancer-related MicroRNAs, PLoS One, 12, e0168412, 10.1371/journal.pone.0168412 · DOI
  134. Git, 2010, Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression, RNA, 16, 991, 10.1261/rna.1947110 · DOI · Paper page
  135. Guo, 2010, Mammalian microRNAs predominantly act to decrease target mRNA levels, Nature, 466, 835, 10.1038/nature09267 · DOI · Paper page
  136. Martinez-Sanchez, 2013, MicroRNA target identification-experimental approaches, Biology (Basel), 2, 189
  137. Thomson, 2011, Experimental strategies for microRNA target identification, Nucleic Acids Res., 39, 6845, 10.1093/nar/gkr330 · DOI · Paper page
  138. Filip, 2021, Profiling of MicroRNA targets using activity-based protein profiling: linking enzyme activity to microRNA-185 function, Cell Chem. Biol., 28, 202, 10.1016/j.chembiol.2020.12.009 · DOI
  139. O'Sullivan, 2017, Parallel mRNA, proteomics and miRNA expression analysis in cell line models of the intestine, World J. Gastroenterol., 23, 7369, 10.3748/wjg.v23.i41.7369 · DOI
  140. Sedaghat, 2018, Combining supervised and unsupervised learning for improved miRNA target prediction, IEEE/ACM Trans. Comput. Biol. Bioinform., 15, 1594, 10.1109/TCBB.2017.2727042 · DOI
  141. Rokavec, 2023, Meta-analysis of miR-34 target mRNAs using an integrative online application, Comput. Struct. Biotechnol. J., 21, 267, 10.1016/j.csbj.2022.12.003 · DOI
  142. Wang, 2009, Correlation of expression profiles between microRNAs and mRNA targets using NCI-60 data, Bmc Genomics [Electronic Resource], 10, 218
  143. Abel, 2021, Gene reporter assays to study miRNA function, Methods Mol. Biol., 2300, 119, 10.1007/978-1-0716-1386-3_12 · DOI
  144. Chou, 2018, miRTarBase update 2018: a resource for experimentally validated microRNA–target interactions, Nucleic Acids Res., 46, D296, 10.1093/nar/gkx1067 · DOI
  145. Kuhn, 2008, Experimental validation of miRNA targets, Methods, 44, 47, 10.1016/j.ymeth.2007.09.005 · DOI
  146. Riolo, 2020, miRNA targets: from prediction tools to experimental validation, Methods Protoc., 4, 1, 10.3390/mps4010001 · DOI
  147. Hu, 2022, Survey of the binding preferences of RNA-binding proteins to RNA editing events, Genome Biol., 23, 169, 10.1186/s13059-022-02741-8 · DOI
  148. Arnold, 2012, Cis-acting polymorphisms affect complex traits through modifications of microRNA regulation pathways, PLoS One, 7, e36694, 10.1371/journal.pone.0036694 · DOI
  149. Bhattacharya, 2017, Systematic prediction of the impacts of mutations in MicroRNA seed sequences, J. Integr. Bioinform., 14, 20170001, 10.1515/jib-2017-0001 · DOI
  150. Donnelly, 2022, The developmentally timed decay of an essential microRNA family is seed-sequence dependent, Cell Rep., 40, 111154, 10.1016/j.celrep.2022.111154 · DOI
  151. Yang, 2020, In vivo CRISPR screening for phenotypic targets of the mir-35-42 family in C. elegans, Genes Dev., 34, 1227, 10.1101/gad.339333.120 · DOI
  152. Patel, 2020, Robust partitioning of microRNA targets from downstream regulatory changes, Nucleic Acids Res., 48, 9724, 10.1093/nar/gkaa687 · DOI
  153. Kazmierczak, 2021, Construction of a full-length 3′UTR reporter system for identification of cell-cycle regulating MicroRNAs, Methods Mol. Biol., 2329, 81, 10.1007/978-1-0716-1538-6_7 · DOI
  154. Wolter, 2014, 3′LIFE: a functional assay to detect miRNA targets in high-throughput, Nucleic Acids Res., 42, e132, 10.1093/nar/gku626 · DOI
  155. Brustikova, 2018, Cell-based reporter system for high-throughput screening of MicroRNA pathway inhibitors and its limitations, Front. Genet., 9, 45, 10.3389/fgene.2018.00045 · DOI
  156. Beitzinger, 2007, Identification of human microRNA targets from isolated argonaute protein complexes, RNA Biol., 4, 76, 10.4161/rna.4.2.4640 · DOI · Paper page
  157. Chi, 2009, Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps, Nature, 460, 479, 10.1038/nature08170 · DOI · Paper page
  158. Helwak, 2013, Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding, Cell, 153, 654, 10.1016/j.cell.2013.03.043 · DOI · Paper page
  159. Petri, 2018, Identifying miRNA targets using AGO-RIPseq, Methods Mol. Biol., 1720, 131, 10.1007/978-1-4939-7540-2_9 · DOI
  160. Tichy, 2018, Experimental design and data analysis of Ago-RIP-Seq experiments for the identification of microRNA targets, Brief. Bioinform., 19, 918, 10.1093/bib/bbx032 · DOI
  161. Xun, 2019, Purification and Identification of miRNA Target Sites in Genome Using DNA Affinity Precipitation, Front. Genet., 10, 778, 10.3389/fgene.2019.00778 · DOI
  162. Hafner, 2012, Genome-wide identification of miRNA targets by PAR-CLIP, Methods, 58, 94, 10.1016/j.ymeth.2012.08.006 · DOI
  163. Liu, 2013, CLIP-based prediction of mammalian microRNA binding sites, Nucleic Acids Res., 41, e138, 10.1093/nar/gkt435 · DOI
  164. Kaur, 2012, Cell lines: valuable tools or useless artifacts, Spermatogenesis, 2, 1, 10.4161/spmg.19885 · DOI
  165. Li, 2020, High-resolution in vivo identification of miRNA targets by halo-enhanced Ago2 pull-down, Mol. Cell, 79, 167, 10.1016/j.molcel.2020.05.009 · DOI
  166. Chu, 2020, Argonaute binding within 3′-untranslated regions poorly predicts gene repression, Nucleic Acids Res., 48, 7439
  167. Reinkens, 2022, Ago-RIP sequencing identifies new MicroRNA-449a-5p target genes increasing sorafenib efficacy in hepatocellular carcinoma, J. Cancer, 13, 62, 10.7150/jca.66016 · DOI
  168. Androsavich, 2017, Competitive Argonaute-based RNA immunoprecipitation for investigation of transcriptomic response to anti-miR, Methods Mol. Biol., 1517, 91, 10.1007/978-1-4939-6563-2_6 · DOI

Cited by

Sorted by citations

Metadata

Authors
Diener, C., Keller, A., & Meese, E.
Affiliations
  • Saarland University (USAAR), Institute of Human Genetics , 66421 Homburg , Germany
  • Saarland University (USAAR), Chair for Clinical Bioinformatics , 66123 Saarbrücken, Germany
ORCID
Venue
Nucleic Acids Research
Publisher
Oxford University Press (OUP)
Published
2023-11-30
Volume
52
Issue
4
Pages
1544-1557
ISSN
  • 0305-1048
  • 1362-4962
DOI
10.1093/nar/gkad1142
PMC
PMC10899768
Cited by
248
References
12
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
  • Hans-und-Ruth-Giessen-Stiftung
  • Hedwig-Stalter-Stiftung

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review